Head-to-head · Cost-Efficiency Index
Virta Health vs Ascend Vitality
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Virta Health
Cost-first shoppers who want employees/members with type 2 diabetes or metabolic syndrome whose employer/health plan sponsors Virta.
Visit Virta HealthAscend Vitality
Cost-first shoppers who want cash-pay compounded GLP-1 in both injectable and oral-tablet form, outside LA/MS/KS/NM/WV.
Visit Ascend VitalityThe verdict
Virta Health takes it, leading the Cost-Efficiency Index 43 to 42. Virta Health is a nutrition-first, diabetes-reversal and metabolic-health platform, not a primary GLP-1 prescriber -- its own marketing positions its program as a complement to or 'offramp' from weight-loss medications. Ascend Vitality still earns a C — Cost-first shoppers who want cash-pay compounded GLP-1 in both injectable and oral-tablet form, outside LA/MS/KS/NM/WV.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Virta Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Virta Health | Ascend Vitality |
|---|---|---|
| Cost-Efficiency Index | 43/100 | 42/100 |
| Semaglutide / mo | Not disclosed | $199/mo (plus a separate fee, compounded) |
| Tirzepatide / mo | Not disclosed | $299/mo (compounded) |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | $3,588 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #506 | #510 |
Virta Health
43/100Where the value is
- Strong clinical evidence base for nutrition-driven diabetes reversal
- Positions itself as a long-term alternative to lifelong medication dependence
- Enterprise-grade platform backed by employer and health-plan contracts
The tradeoffs
- Not primarily a GLP-1 prescribing service -- medications are secondary to the nutrition program
- No direct-to-consumer, cash-pay enrollment exists
Ascend Vitality
42/100Where the value is
- Both injectable and oral-tablet forms of semaglutide and tirzepatide are offered — a rare combination
- LegitScript certified, with '503A Pharmacy Approved' and FDA-approved-facility manufacturing claims displayed
- Real 6-month prepay discount on semaglutide ($199/mo down to $176/mo), not just a first-month teaser
The tradeoffs
- The homepage's 'Fall Promo Applied! $120 Off' banner is layered on top of the $199/$299 base price, so the number a shopper sees first is a temporary promotional rate
- All medications are compounded — not FDA-reviewed for safety or effectiveness
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.